| Date Filed | Type | Description |
| 02/02/2007 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/10/2006 |
SC 13G/A
| EARNEST PARTNERS LLC reports a 0% stake in Serologicals Corporation |
| 08/07/2006 |
SC 13G/A
| COLUMBIA WANGER ASSET MANAGEMENT LP has filed a Schedule 13D for SEROLOGICALS CORP |
| 07/10/2006 |
SC 13G/A
| FMR CORP reports a 0.4% stake in Serologicals Corporation |
| 06/09/2006 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 05/12/2006 |
10-Q
| Quarterly Report for the period ended April 2, 2006 |
| 05/11/2006 |
SC 13G/A
| TRANSAMERICA INVESTMENT MANAGEMENT LLC reports a 0.2% stake in SEROLOGICALS CORP |
| 05/10/2006 |
SC 13G/A
| FMR CORP reports a 7.6% stake in Serologicals Corporation |
| 05/08/2006 |
SC 13G
| CHESAPEAKE PARTNERS MANAGEMENT CO INC reports a 5.5% stake in SEROLOGICALS CORPORATION |
| 05/05/2006 |
8-K
| Quarterly results |
| 05/01/2006 |
8-K
| Quarterly results |
| 04/28/2006 |
8-K
| Credit agreement amendment |
| 04/25/2006 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 04/25/2006 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 04/25/2006 |
8-K
| Quarterly results, Acquisition/merger/asset purchase announced |
| 04/11/2006 |
SC 13G
| TRANSAMERICA INVESTMENT MANAGEMENT LLC reports a 5% stake in SEROLOGICALS CORP |
| 04/07/2006 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 03/27/2006 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"Stock Purchase Agreement, by and among Upstate Group, L.L.C., The Ronald L. Gingerich Revocable Living Trust and Ronald L. Gingerich",
"Purchase and Sale Agreement, by and between Upstate Group, L.L.C. and Paragon Properties, L.C",
"SEROLOGICALS CORPORATION AGREES TO ACQUIRE LINCO Solidifies Serologicals as a Leader in Multiplexing Marketplace",
"Conference Call Transcript—Serologicals Corporation Acquisition Review, held on March 24, 2006 at 9:00 a.m. EST" |
|
| 03/16/2006 |
10-K
| Annual Report for the period ended January 1, 2006 |
| 03/08/2006 |
8-K
| Director compensation was amended/approved |
| 03/01/2006 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year |
| 02/27/2006 |
8-K
| Quarterly results |
| 02/16/2006 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 02/16/2006 |
5
| KRAMER JAMES J (Vice President) has filed a Form 5 on SEROLOGICALS CORP |
| 02/16/2006 |
5
| COLLINS ROBERT P (Vice President) has filed a Form 5 on SEROLOGICALS CORP |
| 02/14/2006 |
SC 13G
| COLUMBIA WANGER ASSET MANAGEMENT LP reports a 7.8% stake in Serologicals Corporation |
| 02/10/2006 |
SC 13G/A
| KING LUTHER CAPITAL MANAGEMENT CORP reports a 5.1% stake in Serologicals Corporation |
| 02/10/2006 |
SC 13G
| BARCLAYS PLC reports a 0% stake in Serologicals Corp |
| 02/07/2006 |
SC 13G/A
| EARNEST PARTNERS LLC reports a 12.7% stake in Serologicals Corporation |
| 02/06/2006 |
SC 13G/A
| BROWN CAPITAL MANAGEMENT INC reports a 5.9% stake in * Serologicals Corporation |
| 02/02/2006 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 01/10/2006 |
SC 13G/A
| FMR CORP reports a 14.9% stake in Serologicals Corporation |
| 01/10/2006 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 01/06/2006 |
8-K
| Cost Associated with Exit or Disposal Activities, Material Impairments |
|